Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.-论文-万方医学网

第一作者： Elisa,Rumi

第一单位： Department of Molecular Medicine, University of Pavia, Pavia, Italy.;Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

作者： Elisa,Rumi ^[1] ; Emanuela,Sant'Antonio ^[2] ; Chiara,Cavalloni ^[3] ; Giuditta,Comolli ^[4] ; Virginia Valeria,Ferretti ^[5] ; Irene,Cassaniti ^[6] ; Daniela,Pietra ^[3] ; Chiara,Trotti ^[5] ; Michele,Ciboddo ^[5] ; Milena,Furione ^[6] ; Daniele,Vanni ^[5] ; Ilaria Carola,Casetti ^[5] ; Cristina,Favaron ^[5] ; Fausto,Baldanti ^[7] ; Luca,Arcaini ^[1] ; Mario,Cazzola ^[1]

作者单位： Department of Molecular Medicine, University of Pavia, Pavia, Italy.;Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[1] UOC Ematologia Aziendale, Azienda USL Toscana Nord Ovest, Lucca, Italy. ^[2] Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[3] Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.;Experimental Research Laboratories, Biotechnology Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[4] Department of Molecular Medicine, University of Pavia, Pavia, Italy. ^[5] Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[6] Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.;Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy. ^[7]

主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);巨细胞病毒(Cytomegalovirus);巨细胞病毒感染(Cytomegalovirus Infections);爱泼斯坦巴尔病毒感染(Epstein-Barr Virus Infections);女(雌)性(Female);随访研究(Follow-Up Studies);疱疹病毒4型, 人(Herpesvirus 4, Human);人类(Humans);干扰素γ(Interferon-gamma);男(雄)性(Male);中年人(Middle Aged);骨髓增殖性疾病(Myeloproliferative Disorders);腈类(Nitriles);预后(Prognosis);吡唑类(Pyrazoles);嘧啶类(Pyrimidines);存活率(Survival Rate);病毒载量(Viral Load);病毒激活(Virus Activation)

DOI 10.1002/hon.2769

PMID 32583904

发布时间 2021-12-04

检索历史清除

Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.

Hematological oncology

相似文献

Hematological oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.

Hematological oncology

相似文献

Hematological oncology

相关期刊

检索历史清除